Hanno, Japan

Mamoru Kiniwa

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Saitama, JP (2001)
  • Hanno, JP (2011)
  • Tokushima, JP (2012)

Company Filing History:


Years Active: 2001-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mamoru Kiniwa: Innovator in Therapeutic Agents

Introduction

Mamoru Kiniwa is a notable inventor based in Hanno, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of diabetic neuropathy and herpesvirus-derived pain. With a total of 3 patents to his name, Kiniwa's work has the potential to impact many lives.

Latest Patents

Kiniwa's latest patents include a therapeutic agent for diabetic neuropathy. This agent comprises (±)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]-ethyl]dimethylsulfonium p-toluenesulfonate as an active ingredient. Another significant patent is for a herpesvirus-derived therapeutic agent for pain, which also utilizes (±)-[2-[4-(3-ethoxy-2-hydroxy-propoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate as its active component.

Career Highlights

Throughout his career, Kiniwa has worked with prominent organizations such as Taiho Pharmaceutical Company Limited and Juntendo Educational Foundation. His experience in these institutions has allowed him to develop and refine his innovative ideas in therapeutic treatments.

Collaborations

Some of his notable coworkers include Shozo Yamada and Toshiyuki Hosoya. Their collaboration has likely contributed to the advancements in the therapeutic agents developed by Kiniwa.

Conclusion

Mamoru Kiniwa's contributions to the field of therapeutic agents demonstrate his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of medical needs and a drive to create effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…